Adamas to present at upcoming piper sandler conference

Emeryville, calif., nov. 18, 2020 (globe newswire) -- adamas pharmaceuticals, inc. (nasdaq: adms), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that neil f. mcfarlane, the company's chief executive officer, will participate in a fireside chat at the piper sandler 32nd annual virtual healthcare conference being held december 1-3, 2020.
ADMS Ratings Summary
ADMS Quant Ranking